India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Aarti Drugs Ltd.

Income Statement - Consolidated

Market Cap.(`)	4139.09 Cr.	P/BV	3.24	Book Value (`)	139.96
52 Week High/Low ( ` )	635/312	FV/ML	10/1	P/E(X)	24.61
Book Closure	04/02/2025	EPS (`)	18.42	Div Yield (%)	0.22

(` in Crs.)

You can view the Consolidated Income Statement for the last 5 years.

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	2387.03	2508.87	2705.57	2488.65	2154.78
Other Operating Revenues	0.00	19.71	10.49	0.00	0.00
Total Operating Revenues	2387.03	2528.58	2716.05	2488.65	2154.78

Other Income	16.36	4.03	2.19	11.32	4.53
Total Revenue	2403.39	2532.61	2718.25	2499.96	2159.30

EXPENSES
Cost Of Materials Consumed	1438.30	1571.98	1768.97	1666.36	1221.52
Purchase Of Stock-In Trade	84.34	80.23	121.29	108.57	111.24
Operating And Direct Expenses	0.00	346.28	334.09	295.98	233.43
Changes In Inventories Of FG,WIP And Stock-In Trade	19.46	25.51	-1.75	-86.08	-11.72
Employee Benefit Expenses	112.10	102.34	92.02	82.81	80.50
Finance Costs	35.87	33.52	33.29	20.75	22.96
Depreciation And Amortisation Expenses	55.78	51.45	50.32	50.05	49.88
Other Expenses	445.77	85.77	95.83	91.58	82.71
Total Expenses	2191.62	2297.08	2494.07	2230.01	1790.52

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	211.77	235.53	224.18	269.96	368.79

Exceptional Items	0.00	0.00	0.00	0.00	0.22
Profit/Loss Before Tax	211.77	235.53	224.18	269.96	369.01

Tax Expenses-Continued Operations
Current Tax	43.67	59.56	58.86	69.74	93.00
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	-0.08
Deferred Tax	0.00	4.37	-1.03	-4.78	-4.46
Total Tax Expenses	43.67	63.94	57.82	64.96	88.62
Profit/Loss After Tax And Before ExtraOrdinary Items	168.10	171.59	166.36	205.00	280.40

Profit/Loss From Continuing Operations	168.10	171.59	166.36	205.00	280.40

Profit/Loss For The Period	168.10	171.59	166.36	205.00	280.40

Minority Interest	0.06	-0.17	-0.05	0.04	0.01
Consolidated Profit/Loss After MI And Associates	168.16	171.42	166.31	205.04	280.41

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	18.35	18.56	17.97	22.12	30.09
Diluted EPS (Rs.)	18.35	18.56	17.97	22.12	30.09

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	9.19	9.26	9.26	23.30

Aarti Drugs Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	4139.09 Cr.	P/BV	3.24	Book Value (`)	139.96
52 Week High/Low ( ` )	635/312	FV/ML	10/1	P/E(X)	24.61
Book Closure	04/02/2025	EPS (`)	18.42	Div Yield (%)	0.22

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	912.70	919.35	926.00	926.00	932.00

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	91.27	91.94	92.60	92.60	93.20
Total Share Capital	91.27	91.94	92.60	92.60	93.20

Reserves and Surplus	1277.73	1189.61	1099.83	943.76	820.22
Total Reserves and Surplus	1277.73	1189.61	1099.83	943.76	820.22
Total Shareholders Funds	1369.00	1281.55	1192.43	1036.36	913.42
Minority Interest	0.34	0.41	0.23	-0.06	-0.02

NON-CURRENT LIABILITIES
Long Term Borrowings	284.00	275.33	204.68	138.50	147.56
Deferred Tax Liabilities [Net]	78.23	75.71	70.97	72.43	77.13
Other Long Term Liabilities	1.81	1.08	12.84	11.44	10.89
Long Term Provisions	4.33	2.74	7.27	9.23	21.67
Total Non-Current Liabilities	368.37	354.86	295.75	231.60	257.25

CURRENT LIABILITIES
Short Term Borrowings	328.24	287.09	401.84	399.84	157.21
Trade Payables	416.14	425.49	480.27	468.67	329.97
Other Current Liabilities	88.30	80.01	46.50	67.83	105.38
Short Term Provisions	4.29	2.95	4.37	3.71	2.80
Total Current Liabilities	836.97	795.54	932.98	940.06	595.36

Total Capital And Liabilities	2574.68	2432.36	2421.40	2207.96	1766.01

ASSETS
NON-CURRENT ASSETS
Tangible Assets	858.95	809.91	675.43	689.78	665.14
Intangible Assets	7.15	1.18	0.79	0.15	0.26
Capital Work-In-Progress	330.18	225.23	210.35	76.74	19.26
Intangible Assets Under Development	0.00	35.65	0.00	0.00	0.00
Fixed Assets	1196.28	1071.96	886.58	766.67	684.66
Non-Current Investments	22.41	19.97	18.80	19.48	17.30
Other Non-Current Assets	17.63	19.70	23.67	28.44	7.26
Total Non-Current Assets	1236.32	1111.64	929.05	814.59	709.22


CURRENT ASSETS
Inventories	472.93	485.89	516.29	525.94	415.00
Trade Receivables	751.18	704.55	864.84	749.90	555.23
Cash And Cash Equivalents	7.56	9.43	8.96	22.33	9.78
Short Term Loans And Advances	0.76	0.24	0.00	0.00	0.00
OtherCurrentAssets	105.93	120.61	102.26	95.20	76.79
Total Current Assets	1338.36	1320.72	1492.35	1393.37	1056.80

Total Assets	2574.68	2432.36	2421.40	2207.96	1766.01

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	281.02	262.94	211.49	155.67

BONUS DETAILS
Bonus Equity Share Capital	0.00	87.02	87.02	87.02	87.59

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	19.97	18.80	19.48	17.30

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Aarti Drugs Ltd.

Income Statement - Consolidated

Aarti Drugs Ltd.

Balance Sheet - Consolidated